Director/PDMR Shareholding

RNS Number : 2233L

GlaxoSmithKline PLC

06 January 2009

 



Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

I give below details of changes in the directors' interests in the Ordinary shares and American Depository Shares (ADSs) of GlaxoSmithKline plc.

On 31 December 2008, the Company's Non-Executive Directors were provisionally allocated the following awards over Ordinary shares at a price of £12.58 per Ordinary share and $36.51 per ADS under the share allocation arrangements for Non-Executive Directors for the period of service from 1 October 2008 to 31 December 2008:

Non Executive Director	Ordinary Shares	American Depository Shares (ADSs)
Sir Christopher Gent	2,682.83
Prof. Sir Roy Anderson	521.66
Dr Stephanie Burns		920.61
Mr Lawrence Culp		1,432.07
Sir Crispin Davis	1,490.46
Sir Deryck Maughan		1,432.07
Dr Daniel Podolsky		1,125.20
Sir Ian Prosser	1,043.32
Dr Ronaldo Schmitz	596.18
Mr Tom de Swaan	521.66
Sir Robert Wilson	471.98

The Company and the Non-Executive Directors were informed of these allocations on 5 January 2009.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

S M Bicknell

Company Secretary

6 January 2009

 

END

 

 

RDSDQLFBKFBLBBK